The challenges and trends of cell & gene therapiesÂ
Drug Discovery World
SEPTEMBER 6, 2022
With the sector looking strong it would be easy to think of the cell & gene sector as being resilient to challenge but this is never the case in pharma: fierce competition can result in fluctuating valuations for listed companies and the regulatory hurdles of pharma means that many companies won’t ever see their product reach the bedside. .
Let's personalize your content